Aduro Biotech to Present at the Bank of America Merrill Lynch 2018 Health Care Conference

May 10, 2018 4:01 p.m. ET BERKELEY, Calif., May 10, 2018 (GLOBE NEWSWIRE) — Aduro Biotech, Inc. (NASDAQ:ADRO) today announced that Stephen T. Isaacs, chairman, president and chief executive officer of Aduro, will present at the Bank of America Merrill Lynch 2018 Health Care Conference in Las Vegas, NV on Thursday, May 17, 2018,

Aduro Biotech Presents Early Observations From its Personalized Neoantigen-based pLADD Therapy Clinical Study at European Neoantigen Summit

April 26, 2018 8:00 a.m. ET pLADD Therapy Found to Induce Both Innate and Adaptive Immunity BERKELEY, Calif., April 26, 2018 (GLOBE NEWSWIRE) — Aduro Biotech, Inc. (Nasdaq:ADRO) today presented preliminary observations from a case study of a patient with metastatic colorectal cancer treated in Aduro’s